{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:40:08Z","timestamp":1748972408535,"version":"3.41.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>A 29-year-old Korean woman with chronic aplastic anemia presented with seizures due to cyclosporine-induced posterior reversible encephalopathy syndrome, caused by unpredictable oral cyclosporine (CS) accumulation and prolonged elimination. This case demonstrates the need to monitor CS drug levels with careful dose adjustments.<\/jats:p>","DOI":"10.1097\/ftd.0000000000001244","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T17:21:29Z","timestamp":1724865689000},"page":"563-566","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Unpredictable Cyclosporine Clearance in a Korean Patient With Aplastic Anemia With Adverse Effects: A Case Study"],"prefix":"10.1097","volume":"46","author":[{"given":"Renata","family":"Shihmanter","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Unit, Kaplan Medical Center, Rehovot;"},{"name":"Hebrew University Hadassah Medical School, Jerusalem; and"},{"name":"Department of Medicine, Kaplan Medical Center, Rehovot, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward B.","family":"Miller","sequence":"additional","affiliation":[{"name":"Hebrew University Hadassah Medical School, Jerusalem; and"},{"name":"Department of Medicine, Kaplan Medical Center, Rehovot, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Shvartsman","sequence":"additional","affiliation":[{"name":"Hebrew University Hadassah Medical School, Jerusalem; and"},{"name":"Department of Medicine, Kaplan Medical Center, Rehovot, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Shmuely","sequence":"additional","affiliation":[{"name":"Hebrew University Hadassah Medical School, Jerusalem; and"},{"name":"Department of Medicine, Kaplan Medical Center, Rehovot, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1345\/aph.1K62B","article-title":"Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?","volume":"42","author":"Lam","year":"2008","journal-title":"Ann Pharmacother."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1345\/aph.10380","article-title":"Factors influencing cyclosporine blood concentration-dose ratio","volume":"36","author":"Garc\u00eda-S\u00e1iz","year":"2002","journal-title":"Ann Pharmacother."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5021\/ad.2015.27.4.454","article-title":"Cyclosporine-induced posterior reversible encephalopathy syndrome in a patient with pemphigus vulgaris","volume":"27","author":"Park","year":"2015","journal-title":"Ann Dermatol."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMra2114482","article-title":"Posterior reversible encephalopathy syndrome","volume":"388","author":"Geocadin","year":"2023","journal-title":"N Engl J Med."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3904\/kjim.2014.29.6.713","article-title":"Recent advances in treatment of aplastic anemia","volume":"29","author":"Shin","year":"2014","journal-title":"Korean J Intern Med."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1592\/phco.31.6.574","article-title":"Population pharmacokinetics of cyclosporine in Korean adults undergoing living-donor kidney transplantation","volume":"31","author":"Ji","year":"2011","journal-title":"Pharmacotherapy"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MAJ.0000000000000337","article-title":"Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients","volume":"348","author":"Xue","year":"2014","journal-title":"Am J Med Sci."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1038\/psp.2013.78","article-title":"Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on cyclosporine, everolimus, and tacrolimus pharmacokinetics in renal transplantation","volume":"3","author":"Moes","year":"2014","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"145325","DOI":"10.1155\/2014\/145325","article-title":"Cyclosporine and herbal supplement interactions","volume":"2014","author":"Colombo","year":"2014","journal-title":"J Toxicol."},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.jfda.2018.01.009","article-title":"Food-drug interactions precipitated by fruit juices other than grapefruit juice: an update review","volume":"26","author":"Chen","year":"2018","journal-title":"J Food Drug Anal."},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/ecp.11.30","article-title":"Duration of drug interactions: putative time courses after mechanism-based inhibition or induction of CYPs","volume":"4","author":"Imai","year":"2011","journal-title":"Expert Rev Clin Pharmacol."},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"e13098","DOI":"10.1111\/ctr.13098","article-title":"Using known drug interactions to manage supratherapeutic calcineurin inhibitor concentrations","volume":"31","author":"Lange","year":"2017","journal-title":"Clin Transplant"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:10:39Z","timestamp":1748970639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001244","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"2024-03-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}